BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 9, 2010
View Archived Issues
Indian scientists claim new inhibitors of TNF-alpha production
Read More
Cornerstone Pharma adds new site for phase I/II CPI-613 trials in cancer
Read More
Southern Research Institute discloses novel antiviral agents
Read More
MannKind discloses new agents for pulmonary drug delivery
Read More
Mallinckrodt discovers new diagnostics for renal disorders
Read More
Novavax's influenza VLP vaccine triggers cytotoxic T-cell proliferation and IFN-gamma secretion
Read More
Clinical data presented on abciximab vs. eptifibatide in PCI
Read More
BPR-0912 exhibits antiobesity effects in vivo
Read More
Lundbeck identifies highly selective M1 receptor agonist
Read More
Lpath provides update on four drug development programs
Read More
Galapagos acquires full rights to GLPG-0634 for arthritis
Read More
FDA grants fast track status to ACE-031 in Duchenne's muscular dystrophy
Read More
Agennix presents update on talactoferrin in cancer and severe sepsis
Read More
GlaxoSmithKline presents new antimycobacterial agents
Read More
Elder Pharmaceuticals discovers new glucose-lowering agents
Read More
Cell Therapeutics reports on second quarter 2010
Read More
Italian scientists identify new EGFR inhibitors
Read More
Clavis advances phase II gemcitabine elaidate trial in pancreatic cancer
Read More
GenVec and Novartis expand collaboration on hearing loss and balance disorders
Read More
Impax Laboratories and Perrigo collaborate on topical drug products
Read More
FDA to complete review of lorcaserin NDA in October
Read More
Glycotope begins phase I trial of GT-MAb 5.2-GEX in cancer
Read More
FDA does not grant orphan drug status to Levulan PDT for SCC prevention
Read More
FDA approves update of Isentress label with 96-week data of trials in HIV-1 infection
Read More
Sunesis partners for phase III VALOR trial of vosaroxin in AML
Read More